Cardiac Event Clinical Trial
Official title:
Correlation Between Cardiac Markers and Severity of COVID-19 in Egyptian Population
By July 9, 2020, the global pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection had resulted in over 11.8 million confirmed cases and over 545000 deaths. Patients with a history of cardiovascular disease are especially vulnerable and have a bad prognosis. According to the findings, cardiac injury manifested by cardiac biomarker elevation is detected in a significant number of COVID-19 patients and is linked to poor outcomes and mortality. However, it is unclear how effective cardiac biomarkers are in COVID-19 prognosis and how to use these indicators.
The pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has led to >11.8 million confirmed cases with >545000 deaths worldwide by July 9, 2020 Patients with preexisting cardiovascular conditions are particularly at risk and have poor prognosis data suggest that cardiac injury, manifested by cardiac biomarker elevation, is detected in a sizable of COVID-19 patients and is associated with adverse outcomes and increased mortality. However, how useful cardiac biomarkers are in COVID-19 prognosis and how to utilize these markers have not been well defined The study will include all moderate to severe COVID 19 patients admitted to ICU. Both genders within the age group 18-60 years were included. The primary outcome is the relation between cardiac markers and mortality rate in critically ill COVID 19 patients The secondary outcome is the relationship between cardiac and inflammatory and coagulation markers ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02814084 -
Prevena Incision Management
|
N/A | |
Not yet recruiting |
NCT05897710 -
Virtual World-Based Cardiac Rehabilitation
|
N/A | |
Recruiting |
NCT05200078 -
Deep Inspiration Breath-hold Radiotherapy for Left-sided Breast Cancer
|
||
Completed |
NCT05710796 -
AN OBSERVATIONAL STUDY ON CARDIOVASCULAR INVOLVEMENT IN COVID RECOVERED PATIENTS
|
||
Recruiting |
NCT04573049 -
The Effectiveness and Safety of Levosimendan in Patients With Severe Aortic Stenosis and Heart Failure Undergoing Transcatheter Aortic Valve Replacement
|
Phase 4 | |
Not yet recruiting |
NCT03899298 -
Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions
|
Phase 1 | |
Terminated |
NCT03208023 -
RESIPI for Reducing Perioperative Major Adverse Cardiac Events
|
N/A | |
Completed |
NCT05349708 -
Telehealth Home-monitoring for Frailty in Cardiac Surgery
|
N/A | |
Completed |
NCT04596163 -
Transversus Thoracis Muscle Plane Block for Sternotomy Pain in Cardiac Surgery
|
N/A | |
Not yet recruiting |
NCT04696523 -
Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage
|
Phase 2 | |
Completed |
NCT03407573 -
Restrictive vs Liberal Transfusion Strategy on Cardiac Injury in Patients Undergoing Surgery for Fractured Neck Of Femur
|
N/A | |
Completed |
NCT03916861 -
BIA Versus Physician Adjustment in Acute Kidney Injury Patients Requiring Renal Replacement Therapy
|
N/A | |
Active, not recruiting |
NCT05449769 -
Supporting Cardiac Rehabilitation With eNutriCardio
|
N/A | |
Completed |
NCT04156594 -
Preoperative Self-assessment for Cardio-pulmonary Risk Stratification
|
||
Enrolling by invitation |
NCT04002531 -
A One Visit Follow Up of Adults With Fabry Disease Who Started Long-term Enzyme Replacement Therapy As Children
|
N/A | |
Recruiting |
NCT05443321 -
Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes
|
N/A | |
Completed |
NCT01830023 -
Vitality Trial - Sampling Examination Data
|
N/A | |
Completed |
NCT04749147 -
Color Priming and Patient Decision-Making in the Emergency Department: Priming "Threat" in Patients With Low-Risk Chest Pain
|
N/A | |
Recruiting |
NCT05288894 -
Repaired Tetralogy of Fallot Italian Registry
|
||
Completed |
NCT04499612 -
Influence of Cardiac Implantable Electronic Devices on the Hemostatic System
|